Category: NPR

Opioid Case With 2 Ohio Counties As Plaintiffs Set To Go To Trial Next Week

The first federal case against the opioid industry goes to trial Monday. Some companies have settled to avoid trial, others will get their day in court.

Whistleblower Alleges Fraud At A Large Medicare Advantage Plan In Seattle

As the Trump administration calls for expanding access to Medicare Advantage, a federal whistleblower lawsuit accuses a large Medicare Advantage plan of bilking Medicare out of $8 million.

Whistleblower Alleges Fraud At A Large Medicare Advantage Plan In Seattle

As the Trump administration calls for expanding access to Medicare Advantage, a federal whistleblower lawsuit accuses a large Medicare Advantage plan of bilking Medicare out of $8 million.

Hospital Giant Sutter Health Agrees To Settlement In Big Antitrust Fight

Health care costs in Northern California, where Sutter Health dominates, are 20% to 30% higher than in Southern California, even after adjusting for cost of living. Settlement terms aren’t yet public.

Doctors Faced With Tough Decisions Due To Shortage Of Drug Used To Treat Cancer

NPR’s Audie Cornish speaks with Dr. Yoram Unguru, a hematologist and oncologist in Baltimore, about a shortage of vincristine, a drug used to treat childhood cancer.

Poor People Are Still Sicker Than The Rich In Germany, Despite Universal Health Care

Even with generous health coverage, sizable health disparities persist between Hamburg’s wealthier and poorer neighborhoods. Crowding, poor air quality and fewer physicians plague poorer areas.

Trump Is Trying Hard To Thwart Obamacare. How’s That Going?

Though polls show Affordable Care Act protections remain popular in the U.S., President Trump still threatens to drastically change the law if he can’t repeal it. Here are five changes he’s made.

Heads Up: A Ruling On The Latest Challenge To The Affordable Care Act Is Coming

The health law again faces possible legal evisceration with a court ruling in Texas v. Azar anticipated this fall. Here’s what it’s about and what’s stake.

Canada’s Decision To Make Public More Clinical Trial Data Puts Pressure On FDA

The U.S. Food and Drug Administration treats most data it gets on the development of new drugs and medical devices as confidential to companies. Critics say making the data public would help patients.

India Banned E-Cigarettes — But Beedis And Chewing Tobacco Remain Widespread

India is the world’s top consumer of smokeless tobacco — and has the world’s highest number of oral cavity cancers.